Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice

Journal of Controlled Release

Volumn 183, Issue 1, 2014, Pages 114-123

  Zhang, Liang ^a   Zhou, Heling ^a   Belzile, Olivier ^b   Thorpe, Philip ^b   Zhao, Dawen ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bimodal liposomal nanoprobe; Breast cancer; Magnetic resonance imaging (MRI); Near infrared optical imaging; Phosphatidylserine (PS); Tumor vasculature

Indexed keywords

CELL MEMBRANES; DISEASES; ENDOTHELIAL CELLS; INFRARED DEVICES; IONIZING RADIATION; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MAMMALS; MEDICAL IMAGING; MONOCLONAL ANTIBODIES; NANOPROBES; OPTICAL IMAGE STORAGE; SIGNAL SYSTEMS;

BINDING SPECIFICITIES; BREAST CANCER; HUMAN MONOCLONAL ANTIBODIES; LIPOSOMAL NANOPARTICLES; NEAR-INFRARED OPTICAL IMAGING; PHOSPHATIDYLSERINE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; TUMOR VASCULATURE;

TUMORS;

ANTIGEN; BIMODAL LIPOSOMAL NANOPARTICLE; LIPOSOME; MACROGOL; MAGNETIC NANOPARTICLE; NANOCARRIER; NEAR INFRARED DYE; PHOSPHATIDYLSERINE; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TEFIBAZUMAB; UNCLASSIFIED DRUG; CONTRAST MEDIUM; MAGNETITE NANOPARTICLE; MONOCLONAL ANTIBODY;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BIMODAL LIPOSOMAL NANOPROBE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL SURFACE; COLLIMATOR; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG SPECIFICITY; DRUG TARGETING; ELECTRON MICROSCOPE; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; FLUORESCENCE IMAGING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; IONIZING RADIATION; LIPID BILAYER; LIPOSOMAL DELIVERY; LIPOSOMAL NANOPROBE; LIVER; MDA MB231 CELL; MOUSE; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPLEEN; TUMOR VASCULAR ENDOTHELIAL CELL; ANIMAL; BAGG ALBINO MOUSE; BOVINAE; CHEMISTRY; DIAGNOSTIC USE; HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; MOLECULAR IMAGING; PROCEDURES; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CATTLE; CELL LINE, TUMOR; CONTRAST MEDIA; ENDOTHELIAL CELLS; FEMALE; HUMANS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, INBRED BALB C; MOLECULAR IMAGING; PHOSPHATIDYLSERINES;

EID: 84898647966     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.03.043     Document Type: Article

References (44)

1. S. Ran, A. Downes, and P.E. Thorpe Increased exposure of anionic phospholipids on the surface of tumor blood vessels Cancer Res. 62 2002 6132 6140 (Pubitemid 35244462)
2. S. Ran, and P.E. Thorpe Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy Int. J. Radiat. Oncol. Biol. Phys. 54 2002 1479 1484 (Pubitemid 35380052)
3. A.K. Hammill, J.W. Uhr, and R.H. Scheuermann Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death Exp. Cell Res. 251 1999 16 21 (Pubitemid 29406515)
4. B. Mirnikjoo, K. Balasubramanian, and A.J. Schroit Mobilization of lysosomal calcium regulates the externalization of phosphatidylserine during apoptosis J. Biol. Chem. 284 2009 6918 6923
5. K. Balasubramanian, and A.J. Schroit Aminophospholipid asymmetry: a matter of life and death Annu. Rev. Physiol. 65 2003 701 734 (Pubitemid 38249174)
6. J. He, T.A. Luster, and P.E. Thorpe Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids Clin. Cancer Res. 13 2007 5211 5218 (Pubitemid 47502091)
7. J. He, Y. Yin, T.A. Luster, L. Watkins, and P.E. Thorpe Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma Clin. Cancer Res. 15 2009 6871 6880
8. M. Jennewein, M.A. Lewis, D. Zhao, E. Tsyganov, N. Slavine, J. He, L. Watkins, V.D. Kodibagkar, S. O'Kelly, P. Kulkarni, P.P. Antich, A. Hermanne, F. Rosch, R.P. Mason, and P.E. Thorpe Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine Clin. Cancer Res. 14 2008 1377 1385 (Pubitemid 351413918)
9. J.H. Stafford, and P.E. Thorpe Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium Neoplasia 13 2011 299 308
10. D. Zhao, J.H. Stafford, H. Zhou, and P.E. Thorpe Near-infrared optical imaging of exposed phosphatidylserine in a mouse glioma model Transl. Oncol. 4 2011 355 364
11. S. Ran, J. He, X. Huang, M. Soares, D. Scothorn, and P.E. Thorpe Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice Clin. Cancer Res. 11 2005 1551 1562 (Pubitemid 40315240)
12. T.A. Luster, J. He, X. Huang, S.N. Maiti, A.J. Schroit, P.G. de Groot, and P.E. Thorpe Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells J. Biol. Chem. 281 2006 29863 29871 (Pubitemid 44536995)
13. D. Saslow, C. Boetes, W. Burke, S. Harms, M.O. Leach, C.D. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, R.A. Smith, E. Warner, M. Yaffe, K.S. Andrews, and C.A. Russell American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J. Clin. 57 2007 75 89 (Pubitemid 46535708)
14. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160 (Pubitemid 40282557)
15. F. Pastorino, C. Brignole, D. Marimpietri, P. Sapra, E.H. Moase, T.M. Allen, and M. Ponzoni Doxorubicin-loaded Fab′ fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice Cancer Res. 63 2003 86 92 (Pubitemid 36070424)
16. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237 (Pubitemid 20233874)
17. A.A. Gabizon Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy Cancer Invest. 19 2001 424 436 (Pubitemid 32525189)
18. H. Maeda, T. Sawa, and T. Konno Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS J. Control. Release 74 2001 47 61 (Pubitemid 32727608)
19. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760 (Pubitemid 350223348)
20. T.L. Andresen, S.S. Jensen, and K. Jorgensen Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog. Lipid Res. 44 2005 68 97 (Pubitemid 40313220)
21. J.W. Park, D.B. Kirpotin, K. Hong, R. Shalaby, Y. Shao, U.B. Nielsen, J.D. Marks, D. Papahadjopoulos, and C.C. Benz Tumor targeting using anti-her2 immunoliposomes J. Control. Release 74 2001 95 113 (Pubitemid 32727613)
22. P. Sapra, and T.M. Allen Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs Cancer Res. 62 2002 7190 7194 (Pubitemid 36025236)
23. L. Zhang, H.J. Yao, Y. Yu, Y. Zhang, R.J. Li, R.J. Ju, X.X. Wang, M.G. Sun, J.F. Shi, and W.L. Lu Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells Biomaterials 33 2012 565 582
24. D. Sturm, H. Witt, V. Hovestadt, D.A. Khuong-Quang, D.T. Jones, C. Konermann, E. Pfaff, M. Tonjes, M. Sill, S. Bender, M. Kool, M. Zapatka, N. Becker, M. Zucknick, T. Hielscher, X.Y. Liu, A.M. Fontebasso, M. Ryzhova, S. Albrecht, K. Jacob, M. Wolter, M. Ebinger, M.U. Schuhmann, T. van Meter, M.C. Fruhwald, H. Hauch, A. Pekrun, B. Radlwimmer, T. Niehues, G. von Komorowski, M. Durken, A.E. Kulozik, J. Madden, A. Donson, N.K. Foreman, R. Drissi, M. Fouladi, W. Scheurlen, A. von Deimling, C. Monoranu, W. Roggendorf, C. Herold-Mende, A. Unterberg, C.M. Kramm, J. Felsberg, C. Hartmann, B. Wiestler, W. Wick, T. Milde, O. Witt, A.M. Lindroth, J. Schwartzentruber, D. Faury, A. Fleming, M. Zakrzewska, P.P. Liberski, K. Zakrzewski, P. Hauser, M. Garami, A. Klekner, L. Bognar, S. Morrissy, F. Cavalli, M.D. Taylor, P. van Sluis, J. Koster, R. Versteeg, R. Volckmann, T. Mikkelsen, K. Aldape, G. Reifenberger, V.P. Collins, J. Majewski, A. Korshunov, P. Lichter, C. Plass, N. Jabado, and S.M. Pfister Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma Cancer Cell 22 2012 425 437
25. M. Demeule, D. Shedid, E. Beaulieu, R.F. Del Maestro, A. Moghrabi, P.B. Ghosn, R. Moumdjian, F. Berthelet, and R. Beliveau Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors Int. J. Cancer 93 2001 62 66 (Pubitemid 32539502)
26. R. Weissleder, and M.J. Pittet Imaging in the era of molecular oncology Nature 452 2008 580 589 (Pubitemid 351483372)
27. L. Yang, X.H. Peng, Y.A. Wang, X. Wang, Z. Cao, C. Ni, P. Karna, X. Zhang, W.C. Wood, X. Gao, S. Nie, and H. Mao Receptor-targeted nanoparticles for in vivo imaging of breast cancer Clin. Cancer Res. 15 2009 4722 4732
28. D. Artemov Molecular magnetic resonance imaging with targeted contrast agents J. Cell. Biochem. 90 2003 518 524 (Pubitemid 37243699)
29. W. Cai, and X. Chen Multimodality molecular imaging of tumor angiogenesis J. Nucl. Med. 49 Suppl. 2 2008 113S 128S (Pubitemid 351948040)
30. D.A. Sipkins, D.A. Cheresh, M.R. Kazemi, L.M. Nevin, M.D. Bednarski, and K.C. Li Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat. Med. 4 1998 623 626 (Pubitemid 28237365)
31. C. Khemtong, C.W. Kessinger, J. Ren, E.A. Bey, S.G. Yang, J.S. Guthi, D.A. Boothman, A.D. Sherry, and J. Gao In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles Cancer Res. 69 2009 1651 1658
32. A.P. Pathak, M.F. Penet, and Z.M. Bhujwalla MR molecular imaging of tumor vasculature and vascular targets Adv. Genet. 69 2010 1 30
33. L. Zhang, and D. Zhao Liposomal encapsulation enhances in vivo near infrared imaging of exposed phosphatidylserine in a mouse glioma model Molecules 18 2013 14613 14628
34. J.H. Stafford, G. Hao, A.M. Best, X. Sun, and P.E. Thorpe Highly specific PET imaging of prostate tumors in mice with an iodine-124-labeled antibody fragment that targets phosphatidylserine PLoS One 8 2013 e84864
35. A. Ogasawara, J.N. Tinianow, A.N. Vanderbilt, H.S. Gill, S. Yee, J.E. Flores, S.P. Williams, A. Ashkenazi, and J. Marik ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models Nucl. Med. Biol. 40 2013 15 22
36. C. Zhang, M. Jugold, E.C. Woenne, T. Lammers, B. Morgenstern, M.M. Mueller, H. Zentgraf, M. Bock, M. Eisenhut, W. Semmler, and F. Kiessling Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner Cancer Res. 67 2007 1555 1562 (Pubitemid 46383379)
37. N.R. Soman, S.L. Baldwin, G. Hu, J.N. Marsh, G.M. Lanza, J.E. Heuser, J.M. Arbeit, S.A. Wickline, and P.H. Schlesinger Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth J. Clin. Invest. 119 2009 2830 2842
38. D.B. Kirpotin, D.C. Drummond, Y. Shao, M.R. Shalaby, K. Hong, U.B. Nielsen, J.D. Marks, C.C. Benz, and J.W. Park Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 2006 6732 6740 (Pubitemid 44085631)
39. J.W. Bulte, and D.L. Kraitchman Iron oxide MR contrast agents for molecular and cellular imaging NMR Biomed. 17 2004 484 499 (Pubitemid 39549426)
40. D.L. Thorek, A.K. Chen, J. Czupryna, and A. Tsourkas Superparamagnetic iron oxide nanoparticle probes for molecular imaging Ann. Biomed. Eng. 34 2006 23 38
41. M. Zhao, D.A. Beauregard, L. Loizou, B. Davletov, and K.M. Brindle Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent Nat. Med. 7 2001 1241 1244 (Pubitemid 33063780)
42. M. Mitsunaga, M. Ogawa, N. Kosaka, L.T. Rosenblum, P.L. Choyke, and H. Kobayashi Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules Nat. Med. 17 2011 1685 1691
43. E.A. Schellenberger, A. Bogdanov Jr., A. Petrovsky, V. Ntziachristos, R. Weissleder, and L. Josephson Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy Neoplasia 5 2003 187 192 (Pubitemid 36754049)
44. S. Ke, X. Wen, Q.P. Wu, S. Wallace, C. Charnsangavej, A.M. Stachowiak, C.L. Stephens, J.L. Abbruzzese, D.A. Podoloff, and C. Li Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V J. Nucl. Med. 45 2004 108 115 (Pubitemid 47611616)